BXP
BXP Inc.
$51.78
$0.00(0.00%)
47
Overall
65
Value
36
Tech
42
Quality
Market Cap
$10.86B
Volume
2.00M
52W Range
$49.72 - $79.33
Target Price
$71.75
Company Overview
| Mkt Cap | $10.86B | Price | $51.78 |
| Volume | 2.00M | Change | +0.00% |
| P/E Ratio | 760.9 | Open | $50.49 |
| Revenue | $6.6B | Prev Close | $51.78 |
| Net Income | $14.3M | 52W Range | $49.72 - $79.33 |
| Div Yield | 2.80% | Target | $71.75 |
| Overall | 47 | Value | 65 |
| Quality | 42 | Technical | 36 |
No chart data available
About BXP Inc.
BXP, Inc. (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets - Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). Including properties owned by unconsolidated joint ventures, BXP's portfolio totals 53.3 million square feet and 185 properties, including seven properties under construction/redevelopment.
Sector: Real Estate
Industry: REIT - Office
Latest News
Morgan Stanley Sticks to Its Hold Rating for BXP (BXP)
TipRanks Auto-Generated Intelligence Newsdesk•6 days ago
Botanix Showcases FDA-Approved Hyperhidrosis Drug at Euroz Hartleys Conference
TipRanks Australian Auto-Generated Newsdesk•19 days ago
Botanix Revises Securities Purchase Plan Timetable and Sets Approval Date
TipRanks Australian Auto-Generated Newsdesk•a month ago
Botanix updates timetable for share purchase plan securities issue
TipRanks Australian Auto-Generated Newsdesk•a month ago
Botanix Opens Underwritten Security Purchase Plan to Fund Dermatology Growth
TipRanks Australian Auto-Generated Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BXP | $51.78 | 0% | 2.00M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |